Iโm very proud of this work and our efforts to make albuminuria evaluation and management accessible to primary care clinicians. Thank you to @ashunephro.bsky.social and our co-authors for the mentorship, and to the @bmj.com for supporting our work!
26.11.2025 21:58 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0
Low rates of testing could mean that up to two thirds of people at risk for chronic kidney disease may have unrecognised albuminuria.
What should doctors know about interpretation, treatment, & follow-up?
Includes a visual summary - click the link to view in full #MedEd
www.bmj.com/content/391/...
26.11.2025 13:28 โ ๐ 16 ๐ 4 ๐ฌ 0 ๐ 0
Headline: Albuminuria: The "Silent" Risk We Canโt Afford to Miss in Primary Care
I am excited to share our latest article, published today in @bmj.com led by @sophieclaudel.bsky.social : "Assessment and management of albuminuria in adults."
bmj.com/cgi/content/...
25.11.2025 16:26 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 1
Iโm extremely honored to have been chosen as one of this yearโs STAT Wunderkinds and grateful for the incredible support of my mentors @ashunephro.bsky.social and Sus Waikar!! @bu_bmc_renal ๐ #nephsky
www.statnews.com/wunderkinds/
15.10.2025 22:33 โ ๐ 4 ๐ 2 ๐ฌ 1 ๐ 0
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894
@ashunephro.bsky.social @sophieclaudel.bsky.social
17.09.2025 16:00 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 0
Despite repeating proteinuria measurements throughout a patient with CKD's clinical course, clinicians may overlook important temporal patterns that emerge. Read more about proteinuria trajectories and risk of adverse clinical outcomes: kidney.pub/KID0849 #ASNKidney360 @ashunephro.bsky.social
17.07.2025 15:00 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
RMS
Milestone release of #rstats rms package is now on CRAN with a full suite of survival analysis fitting, validation, and graphical display functions based on semiparametric models, generalizing the Cox PH model to a spectrum of models including accelerated failure time. hbiostat.org/r/rms #StatsSky
15.04.2025 15:11 โ ๐ 41 ๐ 7 ๐ฌ 0 ๐ 1
Excited to share our comprehensive review โCardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerationsโ #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social
@asnkidney.bsky.social
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
14.04.2025 23:52 โ ๐ 3 ๐ 0 ๐ฌ 1 ๐ 0
Genetic Testing in Biopsy-Confirmed Kidney Disease
05.04.2025 15:52 โ ๐ 6 ๐ 4 ๐ฌ 0 ๐ 0
Cardiovascularโkidneyโmetabolic (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
28.03.2025 20:35 โ ๐ 6 ๐ 1 ๐ฌ 0 ๐ 0
Cumulative Incidence of Mortality (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
27.03.2025 19:00 โ ๐ 5 ๐ 2 ๐ฌ 1 ๐ 1
Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro.bsky.social in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. ๐ซ
@jaccjournals.bsky.social #NephSky
25.03.2025 21:40 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression.
www.jacc.org/doi/10.1016/...
24.03.2025 23:03 โ ๐ 11 ๐ 5 ๐ฌ 2 ๐ 1
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ๐ฉโ๐ฌ๐ฅผ๐งช๐จโ๐ฌ #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease ๐๐๐
www.ahajournals.org/doi/epub/10....
12.03.2025 08:26 โ ๐ 9 ๐ 3 ๐ฌ 0 ๐ 0
Please let me know your email id.
12.03.2025 17:15 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Send me your email id.
12.03.2025 17:14 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
Extremely grateful to @ahascience.bsky.social and @ashunephro.bsky.social for the opportunity to publish this comprehensive review on albuminuria in #Circulation. We cover albuminuria in the spectrum of #CKM disorders. Please take a look!
@nephjc.bsky.social #NephSky
11.03.2025 12:42 โ ๐ 3 ๐ 3 ๐ฌ 0 ๐ 0
Thank you for highlighting our review!!!
10.03.2025 20:10 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0
Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social
โAlbuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...
@ahascience.bsky.social
@ahajournals.bsky.social
@asnkidney.bsky.social
10.03.2025 19:20 โ ๐ 13 ๐ 6 ๐ฌ 2 ๐ 1
Excited to share this research letter looking at albuminuria values in healthy adults! We followed IFCC guidelines for establishing references ranges, which had not previously been shown in the literature, and consider what โnormalโ should be by sex.
22.02.2025 13:20 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
Albuminuria References Ranges in Healthy US Adults
To the Editor:
We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social โAlbuminuria References Ranges in Healthy US Adultsโ
academic.oup.com/jalm/advance...
21.02.2025 20:29 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 1
Our comprehensive review on โ Diuretics in patients with chronic kidney diseaseโ @natrevneph.bsky.social
07.01.2025 18:31 โ ๐ 7 ๐ 3 ๐ฌ 0 ๐ 0
Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social
06.01.2025 02:22 โ ๐ 6 ๐ 0 ๐ฌ 0 ๐ 1
Adrenal physiology and medicine
vaidya.bwh.harvard.edu
๐ Nephrologist | ๐ฐ๐ท Korea
๐ฅ Founder & Director, Dialysis Clinic
๐ Focused on patient-centered renal care
๐ฌ CKD, HD, HDF, incremental dialysis
Senior Clinical Fellow | Nephrology | SCO | Manchester
Professor of Internal Medicine and Clinical Immunology France Tours University
Trialist
Founder and Coordinator of the European IgA Vasculitis Study Group
Head of the department of International Relations, Tours Medical School
Official Bluesky Account of the Section of Nephrology at Yale Internal Medicine
https://medicine.yale.edu/internal-medicine/nephrol/
Weโre a professional society for glomerular disease experts, founded in 2022.
https://is-gd.org
Nephrologist, passionate about home and improving care. Views are solely my own.
Resident FY2 doctor at Cambridge University Hospitals
Postdoc scientist at UCL and the Wellcome Trust Sanger Institute
Alumnus of the UCL MB/PhD Programme
Studying vasculature and lymphatics in development and disease
#Epidemiology #Episky #Healthequity #Kidney #Nephsky #Auspol #FirstNations #Cycling (but not necessarily in that order). Melbourne, Australia. Own opinions, not advice, yada yada yada
Non- invasive and preventive cardiologist Ascension /UT Austin/ DellMedical school.
Nephrologist, M.D, Ph.D, Passionate about kidney disease stories, Nephrogenomic, IgA nephropathy, hemodialysis and potassium #NephSky, #MedSky, Marseille
MD/PhD โ Postdoc Brigham/Harvard Med
Immunology. Kidneys. Autoimmune Disorders. Basketball. Jazz.
50% of the @immunoboys.bsky.social
Assistant Professor - Geisinger Medical Center
Academic Nephrologist
APD - Nephrology Fellowship
Kidney pharmacist @Wessex Kidney Centre, Portsmouth UK.
Specialist interest - optimising medication reviews for CKD patients.
Renal and Acute Medicine Physician, Cardiff, Wales. PhD in exercise in CKD. Here for education
MSP VA Nephrologist with a Midwest background. Enthusiast for the kidneys and education in healthcare. Tweets/retweets = my own โ advice.
Wife, mom, nephrologist. Passionate about taking care of the whole person and goal directed based therapy. Lover of sarcasm and hockey and pro cycling.
Nephrologist and transplant Physician ๐ซถ ๐ซ|Faculty ๐ฎ๐ณ
๐Nerd |FASN |๐ #ISNGKHA Fellow and Mentor
โ๏ธAcademics|Clinics|Research
& #NephroNuggets
Tweets: own views